BACKGROUND: Obesity is a disease that is highly prevalent in Brazil, and the associated comorbidities represent a major global public health challenge. Botulinum toxin type A (BTX-A) is a potent neurotoxin and inhibitor of gastric smooth muscle activity. In theory, BTX-A administration should promote early satiety and weight loss because it delays gastric emptying by inhibiting acetylcholine-mediated peristalsis, which is primarily responsible for gastric motility. Because results in the literature are discrepant, the efficacy of intragastric injections of BTX-A as a primary treatment for obesity remains unknown. The objective of this prospective, double-blind, single-center randomized study was to evaluate the effects of endoscopic ultrasound-guided intragastric BTX-A injections, as a bridge to bariatric surgery, in super-obese patients. METHODS:Thirty-two super-obese patients were randomized to one of two groups: BTX-A, in which 200 units of BTX-A were injected into the gastric antrum and body; and control, in which the same injections were performed with 0.9% saline. Weight, body mass index (BMI), and loss of excess weight were measured monthly over a 6-month period. Gastric emptying scintigraphy was performed before and after the procedure. RESULTS: The patients in both groups showed significant weight loss over the course of the study (p < 0.001). There were no statistically significant differences between the groups regarding weight loss, excess weight, total loss of excess weight, total weight loss, or change in BMI. CONCLUSIONS: Intragastric injection of BTX-A does not appear to be an effective method of achieving preoperative weight loss in super-obese patients.
RCT Entities:
BACKGROUND:Obesity is a disease that is highly prevalent in Brazil, and the associated comorbidities represent a major global public health challenge. Botulinum toxin type A (BTX-A) is a potent neurotoxin and inhibitor of gastric smooth muscle activity. In theory, BTX-A administration should promote early satiety and weight loss because it delays gastric emptying by inhibiting acetylcholine-mediated peristalsis, which is primarily responsible for gastric motility. Because results in the literature are discrepant, the efficacy of intragastric injections of BTX-A as a primary treatment for obesity remains unknown. The objective of this prospective, double-blind, single-center randomized study was to evaluate the effects of endoscopic ultrasound-guided intragastric BTX-A injections, as a bridge to bariatric surgery, in super-obesepatients. METHODS: Thirty-two super-obesepatients were randomized to one of two groups: BTX-A, in which 200 units of BTX-A were injected into the gastric antrum and body; and control, in which the same injections were performed with 0.9% saline. Weight, body mass index (BMI), and loss of excess weight were measured monthly over a 6-month period. Gastric emptying scintigraphy was performed before and after the procedure. RESULTS: The patients in both groups showed significant weight loss over the course of the study (p < 0.001). There were no statistically significant differences between the groups regarding weight loss, excess weight, total loss of excess weight, total weight loss, or change in BMI. CONCLUSIONS: Intragastric injection of BTX-A does not appear to be an effective method of achieving preoperative weight loss in super-obesepatients.
Entities:
Keywords:
Botulinum toxins; Gastric emptying; Obesity; US endoscopy
Authors: Marius Svanevik; Hilde Risstad; Dag Hofsø; Carl Fredrik Schou; Brita Solheim; Torgeir T Søvik; Jon Kristinsson; Jøran Hjelmesæth; Tom Mala; Rune Sandbu Journal: Obes Surg Date: 2015-10 Impact factor: 4.129
Authors: Igor Braga Ribeiro; Wanderley Marques Bernardo; Bruno da Costa Martins; Diogo Touriani Hourneau de Moura; Elisa Ryoka Baba; Iatagan Rocha Josino; Nelson Tomio Miyahima; Martin Andrés Coronel Cordero; Thiago Arantes de Carvalho Visconti; Edson Ide; Paulo Sakai; Eduardo Guimarães Hourneau de Moura Journal: Endosc Int Open Date: 2018-05-08
Authors: Antonio Afonso de Miranda Neto; Diogo Turiani Hourneaux de Moura; Igor Braga Ribeiro; Ahmad Khan; Shailendra Singh; Alberto Machado da Ponte Neto; Antonio Coutinho Madruga Neto; Epifanio Silvino do Monte Junior; Francisco Tustumi; Wanderley Marques Bernardo; Eduardo Guimarães Hourneaux de Moura Journal: Obes Surg Date: 2020-05 Impact factor: 4.129
Authors: Francisco José Sánchez-Torralvo; Luis Vázquez-Pedreño; Montserrat Gonzalo-Marín; María José Tapia; Fuensanta Lima; Eduardo García-Fuentes; Pilar García; Javier Moreno-Ruiz; Alberto Rodríguez-Cañete; Sergio Valdés; Gabriel Olveira Journal: J Clin Med Date: 2022-04-11 Impact factor: 4.241
Authors: Andrea Telese; Vinay Sehgal; Cormac G Magee; S Naik; S A Alqahtani; L B Lovat; Rehan J Haidry Journal: Clin Transl Gastroenterol Date: 2021-06-18 Impact factor: 4.488
Authors: Aureo Augusto de Almeida Delgado; Diogo Turiani Hourneaux de Moura; Igor Braga Ribeiro; Ahmad Najdat Bazarbashi; Marcos Eduardo Lera Dos Santos; Wanderley Marques Bernardo; Eduardo Guimarães Hourneaux de Moura Journal: World J Gastrointest Endosc Date: 2019-12-16